Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations

Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. This re-analysis of these trials presents solution chemistry methods to elucid...

Descripción completa

Detalles Bibliográficos
Autor principal: Eby, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kluwer Academic Publishers-Plenum Publishers 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087920/
https://www.ncbi.nlm.nih.gov/pubmed/15499830
http://dx.doi.org/10.1023/B:BIRE.0000037754.71063.41
_version_ 1783509433303695360
author Eby, George A.
author_facet Eby, George A.
author_sort Eby, George A.
collection PubMed
description Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. This re-analysis of these trials presents solution chemistry methods to elucidate differences in efficacy. Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials.
format Online
Article
Text
id pubmed-7087920
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Kluwer Academic Publishers-Plenum Publishers
record_format MEDLINE/PubMed
spelling pubmed-70879202020-03-23 Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations Eby, George A. Biosci Rep Article Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. This re-analysis of these trials presents solution chemistry methods to elucidate differences in efficacy. Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials. Kluwer Academic Publishers-Plenum Publishers 2004-02 /pmc/articles/PMC7087920/ /pubmed/15499830 http://dx.doi.org/10.1023/B:BIRE.0000037754.71063.41 Text en © Springer Science+Business Media, Inc. 2004 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Eby, George A.
Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations
title Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations
title_full Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations
title_fullStr Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations
title_full_unstemmed Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations
title_short Zinc Lozenges: Cold Cure or Candy? Solution Chemistry Determinations
title_sort zinc lozenges: cold cure or candy? solution chemistry determinations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087920/
https://www.ncbi.nlm.nih.gov/pubmed/15499830
http://dx.doi.org/10.1023/B:BIRE.0000037754.71063.41
work_keys_str_mv AT ebygeorgea zinclozengescoldcureorcandysolutionchemistrydeterminations

Ejemplares similares